Last reviewed · How we verify

NCT04764591

Tissue Perfusion for Different Approaches of Brachial Plexus Block

Completed NA Last updated 9 February 2024
What this trial tests

NA trial testing Lateral sagittal approach in Upper Extremity Fracture in 60 participants. Completed in 1 December 2022.

Timeline
1 January 2022
Primary endpoint
1 December 2022
1 December 2022

Quick facts

Lead sponsorZonguldak Bulent Ecevit University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment60
Start date1 January 2022
Primary completion1 December 2022
Estimated completion1 December 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Zonguldak Bulent Ecevit University

Who can join

Adults 18 to 65, any sex, with Upper Extremity Fracture or Regional Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the two different approaches of infraclavicular brachial plexus block in forearm, wrist and hand surgery in terms of perfusion index, tissue oxygenation, sensory and motor block onset time and total effect time, first analgesic time, side effects and complications, and duration of block application.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of different approaches of infraclavicular brachial plexus block on perfusion index and tissue perfusion.
    Baytar Ç, Köksal BG. · · 2025 · cited 1× · PMID 39797918 · DOI 10.1080/07853890.2025.2451765

Verify or expand the search:

Other recruiting trials for Upper Extremity Fracture

Currently open trials in the same condition.

Other Zonguldak Bulent Ecevit University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04764591.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing